Toll-like receptor 9 and related nucleic acid-sensing innate immune receptors (TLR9/NASRs)

Toll-like receptor 9 (TLR9) and related nucleic acid-sensing receptors, including TLR3, TLR7, TLR8, and cytosolic sensors like cGAS-STING, are critical components of the innate immune system that detect foreign or misplaced genetic material. TLR9 specifically recognizes unmethylated CpG motifs common in bacterial and viral DNA within endosomal compartments, triggering signaling cascades via MyD88 that lead to the production of Type I interferons and pro-inflammatory cytokines (Kawai & Akira, 2011, Immunity). Other members of this group sense double-stranded RNA (TLR3), single-stranded RNA (TLR7/8), or cytosolic DNA (cGAS), providing a comprehensive surveillance system against pathogens (Wu & Chen, 2014, Annu Rev Immunol). In therapeutic contexts, agonists of these receptors are being developed as vaccine adjuvants and cancer immunotherapies to stimulate anti-tumor T-cell responses (Krieg, 2012, Curr Opin Immunol). Conversely, small molecule antagonists are being investigated for the treatment of autoimmune diseases like systemic lupus erythematosus (SLE), where the chronic sensing of self-nucleic acids drives pathological inflammation (Fillatreau et al., 2021, Nat Rev Rheumatol). These receptors bridge innate and adaptive immunity by activating dendritic cells and B cells, making them versatile targets for infectious disease, oncology, and rheumatology.

Other names

Nucleic acid-sensing receptorsEndosomal Toll-like receptorsDNA and RNA sensorsPattern recognition receptors (PRRs)Intracellular nucleic acid sensors

Agonism of endosomal TLRs to induce type I interferons and pro-inflammatory cytokines for oncology and vaccines; Antagonism of TLR7/8/9 to inhibit auto-antibody-mediated inflammation in autoimmune disorders.